The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Laing O'Rourke Australia is using artificial intelligence tools to reformat existing content into videos that it can use on a ...

AI consultants combine technology and management to develop customized AI solutions. Those who meet the high requirements ...

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

The new AI program will be jointly administered by the Statistics and Data Science Department and the Operations, Information ...

Motion technology has altered the way businesses operate, with important applications in robots and packaging. Over the years ...

Swapna Narla is a technology leader with over 17 years of experience in AI-driven automation, cloud computing, and ...

Discover Geoffrey Hinton’s groundbreaking journey, his Nobel-winning innovations, and why the man who built the future is now ...

In an interview with YourStory, Shailesh Davey, CEO, Zoho Corp, discusses his vision for the company in his new role, elaborates on the company’s AI strategy, and outlines the $20 million bet on ...

Most workers believe AI will influence their jobs and career plans, according to the Jobs for the Future survey, but about ...

Yann LeCun, Meta's chief AI scientist and one of the pioneers of artificial intelligence, believes LLMs will be largely obsolete within five years.

This skills gap extends beyond technical expertise; it also includes understanding AI's potential and pinpointing the right applications across workstreams. Rather than replacing workers, AI should be ...